BBWI
Bath & Body Works Inc
Bath & Body Works Inc historical holders
total: 8
Egerton Capital Bath & Body Works Inc transactions over time
- Total transactions:
- 11
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 4
- Held since:
- 2020 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2022 Q3
John Armitage has been an institutional investor in Bath & Body Works Inc (BBWI) since 2020 Q1. According to 2026 Q2 report, John Armitage doesn't hold any shares. The fund/company first acquired BBWI in 2020 Q1, initially purchasing about 7.67M shares. Since the initial investment, Egerton Capital has made 10 more transactions in this position.
When did John Armitage exit their BBWI position?
John Armitage no longer holds Bath & Body Works Inc (BBWI). They sold off their entire position in 2022 Q3, closing out an investment that began in 2020 Q1.
When did John Armitage first invest in BBWI?
John Armitage first invested in Bath & Body Works Inc (BBWI) in 2020 Q1 at the reported quarter-end price of $11.56 per share, acquiring 7,667,887 shares in their initial purchase.
What is John Armitage's average cost basis for BBWI?
Based on historical transaction data, John Armitage's estimated cost basis for Bath & Body Works Inc (BBWI) is approximately $24.07 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $24.07
- Weighted AVG sell price:
- $35.56
BBWI transactions history by Egerton Capital
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$26.92
|
|
-100% (-7,474,211)
|
-1.36%
|
|
2022 Q2
|
1.36%
|
7,474,211
|
$26.92
|
$201,206,000
|
-45.15% (-6,151,546)
|
-0.87%
|
|
2022 Q1
|
3.43%
|
13,625,757
|
$47.80
|
$651,311,000
|
-0.33% (-45,530)
|
-0.01%
|
|
2021 Q4
|
4.45%
|
13,671,287
|
$69.79
|
$954,119,000
|
-3.08% (-435,089)
|
-0.14%
|
|
2021 Q3
|
4.23%
|
14,106,376
|
$63.03
|
$889,125,000
|
+8.31% (+1,082,199)
|
+0.32%
|
|
2021 Q2
|
4.67%
|
13,024,177
|
$72.06
|
$938,522,000
|
-17.70% (-2,801,113)
|
-1.06%
|
|
2021 Q1
|
5.16%
|
15,825,290
|
$61.86
|
$978,952,000
|
+0.04% (+5,544)
|
+0%
|
|
2020 Q4
|
3.33%
|
$37.19
|
+8.78% (+1,276,710)
|
|||
|
2020 Q3
|
2.86%
|
$31.81
|
+68.22% (+5,897,656)
|
|||
|
2020 Q2
|
0.96%
|
$14.97
|
+12.75% (+977,493)
|
|||
|
2020 Q1
|
0.92%
|
$11.56
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.